Participant consumed grapefruit or grapefruit products within 3 days just before the very first dose of study drug. - "Our study exposed the critical part in the KLF16/MYC regulatory axis in modulating tumor advancement and chemotherapy sensitivity in BLCA, suggesting that combining bromodomain inhibitors, which include OTX015 or ABBV-744, with https://abbv-744inclinicaltrialsf02356.blogsumer.com/31456847/not-known-details-about-brd4-inhibition-by-abbv-744-in-cancer-research-studies